rank	phenotype	cui	assoc in neigh	assoc in intom	probability	Benjamini-Hochberg	genes	
1	Breast-ovarian cancer, familial 1	C0006142	3	4543	0.0	1.38696255201e-06	F2,HSPA5,PROC
2	Renal cell carcinoma, nonpapillary	C0007134	3	1418	0.0	2.77392510402e-06	F2,HSPA5,PROC
3	Colorectal cancer 1	C0009402	3	2543	0.0	4.16088765603e-06	F2,HSPA5,PROC
4	Crohn Disease	C0010346	3	979	0.0	5.54785020804e-06	F2,HSPA5,PROC
5	Diabetes Mellitus, Type 1	C0011849	3	2081	0.0	6.93481276006e-06	F2,HSPA5,PROC
6	Acute type B viral hepatitis	C0019163	3	790	0.0	8.32177531207e-06	F2,HSPA5,PROC
7	Liver Cirrhosis, Biliary	C0023890	3	919	0.0	9.70873786408e-06	F2,HSPA5,PROC
8	Neoplasm of the liver	C0023903	3	1290	0.0	1.10957004161e-05	F2,HSPA5,PROC
9	{Gastric cancer risk after H. pylori infection}, 137215 (3)	C0024623	3	2073	0.0	1.24826629681e-05	F2,HSPA5,PROC
10	Melanoma	C0025202	3	2386	0.0	1.38696255201e-05	F2,HSPA5,PROC
11	Secondary hypertriglyceridemia	C0027627	3	3444	0.0	1.52565880721e-05	F2,HSPA5,PROC
12	Stomach Neoplasms	C0038356	3	916	0.0	1.66435506241e-05	F2,HSPA5,PROC
14	Reduced protein C activity	C0398625	3	32	0.0	1.94174757282e-05	F2,HSPA5,PROC
15	Hereditary hyperhomocysteinemia	C0598608	3	116	0.0	2.08044382802e-05	F2,HSPA5,PROC
16	Ovarian epithelial cancer	C0677886	3	2172	0.0	2.21914008322e-05	F2,HSPA5,PROC
17	Breast carcinoma	C0678222	3	4281	0.0	2.35783633842e-05	F2,HSPA5,PROC
18	Stomach cancer	C0699791	3	2109	0.0	2.49653259362e-05	F2,HSPA5,PROC
20	Colorectal cancer	C1527249	3	2681	0.0	2.77392510402e-05	F2,HSPA5,PROC
21	Coronary Artery Disease	C1956346	3	1366	0.0	2.91262135922e-05	F2,HSPA5,PROC
22	Hepatocellular carcinoma	C2239176	3	3108	0.0	3.05131761442e-05	F2,HSPA5,PROC
32	Lupus anticoagulant disorder	C0311370	2	26	1.1128225008150139e-09	4.43828016644e-05	F2,PROC
33	Thrombophilia due to activated protein C resistance	C1861171	2	26	1.1128225008150139e-09	4.57697642164e-05	F2,PROC
34	Pyruvate carboxylase deficiency	C0034341	2	29	1.5934894515012843e-09	4.71567267684e-05	F2,PROC
35	Protein S deficiency	C0242666	2	30	1.7736974111670634e-09	4.85436893204e-05	F2,PROC
36	Resistance to activated protein C	C0600433	2	35	2.78067868730858e-09	4.99306518724e-05	F2,PROC
37	Disseminated intravascular coagulation	C0012739	2	44	5.707357919604306e-09	5.13176144244e-05	F2,PROC
38	Deep thrombophlebitis	C0151950	2	44	5.707357919604306e-09	5.27045769764e-05	F2,PROC
56	Factor V Leiden mutation	C0584960	2	56	1.1891577056388769e-08	7.76699029126e-05	F2,PROC
68	Abnormal thrombosis	C4025731	2	79	3.390565783689681e-08	9.43134535368e-05	F2,PROC
69	Iron Overload	C0282193	2	83	3.935656256448539e-08	9.57004160888e-05	F2,PROC
70	Chronic ulcerative colitis	C2919828	2	94	5.743189446238972e-08	9.70873786408e-05	F2,PROC
78	Deep venous thrombosis	C0149871	2	112	9.773104281407541e-08	0.000108183079057	F2,PROC
79	Abnormality of coagulation	C1846821	2	113	1.0038403674972329e-07	0.000109570041609	F2,PROC
86	Thromboembolism	C0040038	2	118	1.1444334657717548e-07	0.000119278779473	F2,PROC
87	Thrombophilia	C0398623	2	125	1.3621861949530967e-07	0.000120665742025	F2,PROC
96	Pregnancy Complications	C0032962	2	132	1.605929760284397e-07	0.000133148404993	F2,HSPA5
97	Pulmonary Embolism	C0034065	2	133	1.6429106808324434e-07	0.000134535367545	F2,PROC
98	Abnormality of the pulmonary vasculature	C4025271	2	133	1.6429106808324434e-07	0.000135922330097	F2,PROC
99	Venous thrombosis	C0042487	2	142	2.0025320801586588e-07	0.000137309292649	F2,PROC
100	Neurodegeneration with brain iron accumulation	C0027746	2	144	2.089093951163079e-07	0.000138696255201	F2,HSPA5
111	Peripheral Arterial Disease	C0085096	2	151	2.4112843222123814e-07	0.000153952843273	F2,PROC
112	Thrombosis	C0040053	2	157	2.7124170920433954e-07	0.000155339805825	F2,PROC
121	Subcutaneous hemorrhage	C0854107	2	164	3.094110664347838e-07	0.000167822468793	F2,PROC
122	Internal hemorrhage	C0333285	2	174	3.6991879948100603e-07	0.000169209431345	F2,PROC
128	Bleeding disorder, platelet-type, 21	C0005779	2	177	3.894522594416472e-07	0.000177531206657	F2,PROC
136	Abnormality of blood circulation	C4023585	2	189	4.7469045572068325e-07	0.000188626907074	F2,PROC
137	Fetal Membranes, Premature Rupture	C0015943	2	194	5.13618367836699e-07	0.000190013869626	F2,PROC
138	Chorioamnionitis	C0008495	2	195	5.215985017237301e-07	0.000191400832178	F2,PROC
146	Premature Obstetric Labor	C0022876	2	203	5.888046050728235e-07	0.000202496532594	F2,PROC
147	Variable expressivity	C1861403	2	205	6.06477619791157e-07	0.000203883495146	F2,PROC
148	Benign neoplasm of other endocrine glands	C0086692	2	213	6.806910389789422e-07	0.000205270457698	HSPA5,PROC
153	Hepatoblastoma	C0206624	2	220	7.503808477915541e-07	0.000212205270458	F2,PROC
166	Adenocarcinoma of colon	C0338106	2	240	9.753015168811885e-07	0.000230235783634	HSPA5,PROC
167	Venous Thromboembolism	C1861172	2	240	9.753015168811885e-07	0.000231622746186	F2,PROC
193	Reperfusion Injury	C0035126	2	305	2.0071038879798664e-06	0.000267683772538	F2,HSPA5
194	Lupus Vulgaris	C0024131	2	307	2.0470022847884906e-06	0.00026907073509	F2,HSPA5
199	Non-alcoholic Fatty Liver Disease	C0400966	2	317	2.254212988717086e-06	0.00027600554785	F2,HSPA5
200	Discoid lupus erythematosus	C0024138	2	319	2.2973432640682745e-06	0.000277392510402	F2,HSPA5
201	Abnormal bleeding	C1458140	2	319	2.2973432640682745e-06	0.000278779472954	F2,PROC
202	Recurrent tumor	C0521158	2	320	2.3191147613399465e-06	0.000280166435506	HSPA5,PROC
203	Acute Coronary Syndrome	C0948089	2	320	2.3191147613399465e-06	0.000281553398058	F2,PROC
211	Pulmonary hypertension, neonatal, susceptibility to	C0020542	2	333	2.6143098694753064e-06	0.000292649098474	F2,PROC
212	Hypoxia	C0003130	2	335	2.661867865794143e-06	0.000294036061026	F2,HSPA5
215	Asbestosis	C0003949	1	25	3.0970547280073646e-06	0.000298196948682	HSPA5
216	Leg Ulcer	C0023223	1	25	3.0970547280073646e-06	0.000299583911234	F2
217	Spiegler-Brooke syndrome	C1857941	1	25	3.0970547280073646e-06	0.000300970873786	F2
218	Vascular skin abnormality	C0162819	2	359	3.277918214639186e-06	0.000302357836338	F2,PROC
219	Epidermal cyst	C0014511	1	26	3.3550102791490843e-06	0.00030374479889	PROC
220	Acute hepatitis	C0267797	1	26	3.3550102791490843e-06	0.000305131761442	F2
221	Malignant neoplasm of adrenal cortex	C0346402	1	26	3.3550102791490843e-06	0.000306518723994	PROC
222	Brain Hemorrhage, Traumatic	C0553692	1	26	3.3550102791490843e-06	0.000307905686546	F2
223	Abnormality of the vitreous humor	C4025356	1	26	3.3550102791490843e-06	0.000309292649098	PROC
224	Preeclampsia/eclampsia 1	C0032914	2	371	3.61869402754067e-06	0.00031067961165	F2,PROC
225	Seborrheic keratosis	C0022603	1	27	3.623336353508755e-06	0.000312066574202	PROC
226	Premature Birth	C0151526	2	376	3.767412243838031e-06	0.000313453536755	F2,PROC
227	Hepatitis	C0019159	2	377	3.797613792766441e-06	0.000314840499307	F2,PROC
228	Homocystinuria due to CBS deficiency	C0019880	1	28	3.901915613946372e-06	0.000316227461859	F2
229	Thrombosis of retinal vein	C0035328	1	28	3.901915613946372e-06	0.000317614424411	F2
230	Fulminant hepatitis	C0302809	1	28	3.901915613946372e-06	0.000319001386963	F2
231	Early gastric cancer	C0349530	1	28	3.901915613946372e-06	0.000320388349515	PROC
232	Septicemia	C0036690	2	387	4.108729670382338e-06	0.000321775312067	F2,PROC
233	Recurrent E. coli infections	C0014836	1	29	4.190863296615888e-06	0.000323162274619	F2
234	Femur Head Necrosis	C0015814	1	29	4.190863296615888e-06	0.000324549237171	F2
235	Old myocardial infarction	C0155668	1	29	4.190863296615888e-06	0.000325936199723	F2
236	Carcinoma, Signet Ring Cell	C0206696	1	29	4.190863296615888e-06	0.000327323162275	PROC
237	Hemorrhagic Fever, Ebola	C0282687	1	29	4.190863296615888e-06	0.000328710124827	HSPA5
238	{Systemic lupus erythematosus, susceptibility to, 8} (2)	C0409974	2	393	4.303332779120872e-06	0.000330097087379	F2,HSPA5
239	Familial adenomatous polyposis 1	C0032580	2	395	4.369526795278134e-06	0.000331484049931	HSPA5,PROC
240	Cholangiocarcinoma	C0206698	2	401	4.572178955664086e-06	0.000332871012483	HSPA5,PROC
241	Gingival bleeding	C0017565	1	31	4.799567351665424e-06	0.000334257975035	F2
242	Hemiplegia	C0018991	1	31	4.799567351665424e-06	0.000335644937587	F2
243	Antithrombin III deficiency	C0272375	1	31	4.799567351665424e-06	0.000337031900139	F2
244	Gastrinoma	C0017150	1	32	5.119408229337097e-06	0.000338418862691	PROC
245	Hemorrhagic disorder due to intrinsic circulating anticoagulants	C0019087	1	32	5.119408229337097e-06	0.000339805825243	F2
246	Puerperal Disorders	C0034040	1	32	5.119408229337097e-06	0.000341192787795	F2
247	Respiratory Hypersensitivity	C0035228	1	32	5.119408229337097e-06	0.000342579750347	HSPA5
248	Stenosis	C0678234	1	32	5.119408229337097e-06	0.000343966712899	F2
249	Anterior myocardial infarction	C0340293	1	33	5.449525209977324e-06	0.000345353675451	F2
250	Hepatic steatosis	C0015695	2	427	5.523026979759038e-06	0.000346740638003	F2,HSPA5
251	Paratuberculosis	C0030524	1	34	5.789945867862301e-06	0.000348127600555	F2
252	Venous insufficiency	C0042485	1	34	5.789945867862301e-06	0.000349514563107	PROC
253	Acinar Cell Carcinoma	C0206685	1	34	5.789945867862301e-06	0.000350901525659	PROC
254	Progressive cerebellar degeneration	C0262404	1	34	5.789945867862301e-06	0.000352288488211	HSPA5
255	Adenoviral infections	C0851887	1	34	5.789945867862301e-06	0.000353675450763	PROC
256	Phenotypic variability	C1837514	2	434	5.799778787785037e-06	0.000355062413315	F2,PROC
257	Hepatic encephalopathy	C0019151	1	35	6.1406975390143614e-06	0.000356449375867	F2
258	Multiple Organ Failure	C0026766	1	35	6.1406975390143614e-06	0.000357836338419	PROC
259	Prolonged bleeding time	C0439590	1	36	6.5017506959419435e-06	0.000359223300971	F2
260	Deficiency of glucose-6-phosphate dehydrogenase	C2939465	1	36	6.5017506959419435e-06	0.000360610263523	F2
261	Thyroid cancer, nonmedullary, 4	C0007115	2	453	6.597250591933168e-06	0.000361997226075	HSPA5,PROC
262	Sudden death	C0011071	1	37	6.873132656570746e-06	0.000363384188627	F2
263	Lipoid nephrosis	C0027721	1	37	6.873132656570746e-06	0.000364771151179	HSPA5
264	Odontogenic neoplasm	C0028880	1	37	6.873132656570746e-06	0.000366158113731	PROC
265	SPHEROCYTOSIS, TYPE 1 (disorder)	C2674218	1	37	6.873132656570746e-06	0.000367545076283	PROC
266	Urinary Bladder Neoplasms	C0005695	2	463	7.044883835849447e-06	0.000368932038835	HSPA5,PROC
267	Gangrene	C0017086	1	38	7.254725856609134e-06	0.000370319001387	PROC
268	Ovarian hyperstimulation syndrome	C0085083	1	38	7.254725856609134e-06	0.000371705963939	F2
269	Parathyroid carcinoma	C0687150	1	38	7.254725856609134e-06	0.000373092926491	PROC
270	End Stage Liver Disease	C0745744	1	38	7.254725856609134e-06	0.000374479889043	F2
271	Pregnancy associated hypertension	C0852036	1	38	7.254725856609134e-06	0.000375866851595	F2
272	Hepatocarcinogenesis	C1512409	2	471	7.417204742177219e-06	0.000377253814147	HSPA5,PROC
273	Purpura, Thrombotic Thrombocytopenic	C0034155	1	39	7.646703190200554e-06	0.000378640776699	F2
274	Juvenile polyposis syndrome	C0345893	1	39	7.646703190200554e-06	0.000380027739251	PROC
275	Gastric Cardia Adenocarcinoma	C1333762	1	39	7.646703190200554e-06	0.000381414701803	PROC
276	Hereditary spherocytosis	C0037889	1	40	8.048889896583589e-06	0.000382801664355	PROC
277	Intestinal Cancer	C0346627	1	40	8.048889896583589e-06	0.000384188626907	PROC
278	Carcinogenicity	C0858970	1	40	8.048889896583589e-06	0.000385575589459	PROC
279	Acute myocardial ischemia	C0151744	2	484	8.04988018832109e-06	0.000386962552011	F2,HSPA5
280	Arterial Occlusive Diseases	C0003838	1	41	8.461457732478195e-06	0.000388349514563	F2
281	Pneumonia, Bacterial	C0004626	1	41	8.461457732478195e-06	0.000389736477115	F2
282	Glanzmann thrombasthenia	C0040015	1	41	8.461457732478195e-06	0.000391123439667	F2
283	Japanese Encephalitis	C0014057	1	42	8.8842320926652e-06	0.000392510402219	HSPA5
284	Thrombotic Microangiopathies	C2717961	1	42	8.8842320926652e-06	0.000393897364771	F2
285	Malignant neoplasm of endometrium	C0007103	2	506	9.200730755609676e-06	0.000395284327323	HSPA5,PROC
286	Uterine Corpus Cancer	C0153574	2	506	9.200730755609676e-06	0.000396671289875	HSPA5,PROC
287	Platelet-type bleeding disorder 15	C0005818	1	43	9.317414675136249e-06	0.000398058252427	F2
288	Hyperaldosteronism, familial, type IV	C0020428	1	43	9.317414675136249e-06	0.000399445214979	PROC
289	Deep vein thrombosis of lower limb	C0340708	1	43	9.317414675136249e-06	0.000400832177531	F2
290	Juvenile myoclonic epilepsy	C0270853	1	44	9.760829871030552e-06	0.000402219140083	F2
291	Primary Carcinoma	C1335475	1	44	9.760829871030552e-06	0.000403606102635	PROC
292	Bone necrosis	C0029445	1	45	1.0214534766572747e-05	0.000404993065187	F2
293	Thromboangiitis Obliterans	C0040021	1	45	1.0214534766572747e-05	0.000406380027739	F2
294	Varicose Ulcer	C0042344	1	45	1.0214534766572747e-05	0.000407766990291	F2
295	HELLP Syndrome	C0162739	1	45	1.0214534766572747e-05	0.000409153952843	F2
296	Herpes Simplex Infections	C0019348	2	529	1.0515983903558457e-05	0.000410540915395	HSPA5,PROC
297	Congenital chromosomal disease	C0008626	2	537	1.1001224302642498e-05	0.000411927877947	HSPA5,PROC
298	Kidney Calculi	C0022650	1	47	1.1152807208758553e-05	0.000413314840499	F2
299	Sickle Cell Trait	C0037054	1	47	1.1152807208758553e-05	0.000414701803051	F2
300	Choroidal Neovascularization	C0600518	1	47	1.1152807208758553e-05	0.000416088765603	F2
301	Childhood onset	C1837352	1	47	1.1152807208758553e-05	0.000417475728155	F2
302	Hereditary factor IX deficiency disease	C0008533	1	48	1.1637401956310356e-05	0.000418862690707	F2
303	Xenograft Model	C1520166	2	551	1.1885980786718875e-05	0.000420249653259	HSPA5,PROC
304	Von Willebrand disease, recessive form	C0042974	1	49	1.2132280916454796e-05	0.000421636615811	F2
305	Hemophilia, NOS	C0684275	1	49	1.2132280916454796e-05	0.000423023578363	F2
306	Acute Cerebrovascular Accidents	C0751956	1	49	1.2132280916454796e-05	0.000424410540915	F2
307	Coronary Restenosis	C0948480	1	49	1.2132280916454796e-05	0.000425797503467	F2
308	Nephrosis	C0027720	1	51	1.3152857251563788e-05	0.000427184466019	F2
309	Gorlin syndrome	C0004779	1	54	1.4760894835763594e-05	0.000428571428571	PROC
310	Endometrial Hyperplasia	C0014173	1	54	1.4760894835763594e-05	0.000429958391123	PROC
311	pathologic fistula	C0016169	1	54	1.4760894835763594e-05	0.000431345353675	HSPA5
312	Brain Tumor, Primary	C0750974	1	54	1.4760894835763594e-05	0.000432732316227	PROC
313	Sepsis	C0243026	2	602	1.5508532463681668e-05	0.000434119278779	F2,PROC
314	Sicca Syndrome	C0086981	1	56	1.5884402172372525e-05	0.000435506241331	PROC
315	Chronic neutrophilia	C3665444	1	57	1.646156723411618e-05	0.000436893203883	PROC
316	Hematological neoplasm	C0376545	2	615	1.653685209956901e-05	0.000438280166436	F2,HSPA5
317	Diabetic Nephropathies	C0011881	2	616	1.6617789372785907e-05	0.000439667128988	HSPA5,PROC
318	Henoch-Schoenlein Purpura	C0034152	1	58	1.7048976213018818e-05	0.00044105409154	F2
319	Abnormal pulmonary vein morphology	C0241665	1	58	1.7048976213018818e-05	0.000442441054092	PROC
320	Neoplasm of the parathyroid gland	C0030521	1	59	1.7646714727925783e-05	0.000443828016644	PROC
321	Desmoid tumor	C0079218	1	59	1.7646714727925783e-05	0.000445214979196	PROC
322	Thin skin	C0423757	1	59	1.7646714727925783e-05	0.000446601941748	PROC
323	Small cell lung cancer	C0149925	2	638	1.8465736243977737e-05	0.0004479889043	HSPA5,PROC
324	Metabolic Syndrome X	C0524620	2	638	1.8465736243977737e-05	0.000449375866852	F2,HSPA5
325	Cooley's anemia	C0002875	1	61	1.8873030078525588e-05	0.000450762829404	F2
326	Colonic Polyps	C0009376	1	61	1.8873030078525588e-05	0.000452149791956	PROC
327	Menopause present (finding)	C0150312	1	61	1.8873030078525588e-05	0.000453536754508	F2
328	Hantavirus infection in conditions classified elsewhere and of unspecified site	C0242994	1	61	1.8873030078525588e-05	0.00045492371706	PROC
329	Adenomatous polyp of colon	C0850572	1	61	1.8873030078525588e-05	0.000456310679612	PROC
330	Inflammation	C0021368	2	647	1.925948832048885e-05	0.000457697642164	F2,PROC
331	Ischemia	C0022116	2	647	1.925948832048885e-05	0.000459084604716	F2,HSPA5
332	Other specified disorders of breast	C0006145	1	62	1.9501575244329494e-05	0.000460471567268	PROC
333	Epistaxis	C0014591	1	62	1.9501575244329494e-05	0.00046185852982	F2
334	Turcot syndrome	C0265325	1	62	1.9501575244329494e-05	0.000463245492372	PROC
335	Abnormality of lung morphology	C4021760	2	651	1.9619470930209992e-05	0.000464632454924	F2,PROC
336	Persistent infection	C1264606	1	63	2.01403863372418e-05	0.000466019417476	HSPA5
337	Thyroid carcinoma	C0549473	2	659	2.0352893971842256e-05	0.000467406380028	HSPA5,PROC
338	Bipolar I disorder	C0853193	1	64	2.078946322003894e-05	0.00046879334258	HSPA5
339	Ovarian Serous Adenocarcinoma	C1335177	1	64	2.078946322003894e-05	0.000470180305132	PROC
340	Ameloblastoma	C0002448	1	65	2.1448918939626083e-05	0.000471567267684	PROC
341	Hemolytic uremic syndrome	C0019061	1	65	2.1448918939626083e-05	0.000472954230236	F2
342	Neuroepithelial neoplasm	C0206715	1	65	2.1448918939626083e-05	0.000474341192788	PROC
343	Nasopharyngeal carcinoma, susceptibility to, 3	C2931822	2	671	2.148681726654722e-05	0.00047572815534	HSPA5,PROC
344	Colorectal polyposis	C0949059	1	66	2.2118551041727663e-05	0.000477115117892	PROC
345	Limb ischemia	C2945695	1	66	2.2118551041727663e-05	0.000478502080444	F2
346	Purpura	C0034150	1	67	2.27985309851908e-05	0.000479889042996	PROC
347	Shock, Septic	C0036974	1	69	2.418918188540342e-05	0.000481276005548	F2
348	Primary antiphospholipid syndrome	C0085278	1	69	2.418918188540342e-05	0.0004826629681	F2
349	Abnormality of cardiovascular system physiology	C4023587	2	700	2.4399472646763343e-05	0.000484049930652	F2,PROC
350	Gaucher Disease	C0017205	1	71	2.5621007317289113e-05	0.000485436893204	F2
351	Acute Lung Injury	C0242488	1	71	2.5621007317289113e-05	0.000486823855756	F2
352	Well Differentiated Pancreatic Endocrine Tumor	C1337011	1	71	2.5621007317289113e-05	0.000488210818308	PROC
353	Generalized abnormality of skin	C4021157	2	712	2.5677767083176484e-05	0.00048959778086	F2,PROC
354	Female infertility	C0021361	1	72	2.635230275804812e-05	0.000490984743412	F2
355	Uremia	C0041948	1	72	2.635230275804812e-05	0.000492371705964	PROC
356	Adenomatous Polyps	C0206677	1	72	2.635230275804812e-05	0.000493758668516	PROC
357	Angina pectoris	C0002962	1	73	2.7093880298534323e-05	0.000495145631068	F2
358	Beckwith-Wiedemann syndrome	C0004903	1	73	2.7093880298534323e-05	0.00049653259362	PROC
359	 Cerebrovascular disease, occlusive (3)	C0007820	1	73	2.7093880298534323e-05	0.000497919556172	F2
360	Peutz-Jeghers syndrome	C0031269	1	73	2.7093880298534323e-05	0.000499306518724	PROC
361	Endometrial carcinoma	C0476089	2	726	2.722466488735975e-05	0.000500693481276	HSPA5,PROC
362	Neoplasm of the adrenal cortex	C0001618	1	74	2.7845710596885453e-05	0.000502080443828	PROC
363	Bleeding with minor or no trauma	C0019080	1	74	2.7845710596885453e-05	0.00050346740638	F2
364	Polyposis syndrome, mixed hereditary 1 (4)	C0334108	1	74	2.7845710596885453e-05	0.000504854368932	PROC
365	Homocysteinemia due to MTHFR deficiency	C3495426	1	74	2.7845710596885453e-05	0.000506241331484	F2
366	Granulomatosis with Polyangiitis	C3495801	1	74	2.7845710596885453e-05	0.000507628294036	F2
367	Postoperative Complications	C0032787	1	75	2.8607762748489307e-05	0.000509015256588	F2
368	Complications of Diabetes Mellitus	C0342257	1	75	2.8607762748489307e-05	0.00051040221914	F2
369	Undifferentiated leukemia	C1378511	1	76	2.9380121411737292e-05	0.000511789181692	HSPA5
370	Pancreatic Neoplasms	C0030297	2	750	3.001886697373557e-05	0.000513176144244	HSPA5,PROC
371	Migraine with aura	C0154723	1	77	3.0162729538707467e-05	0.000514563106796	F2
372	Coronary heart disease 7	C0010054	2	754	3.050231529944103e-05	0.000515950069348	F2,HSPA5
373	Protein Deficiency	C0033626	1	78	3.09557000548466e-05	0.0005173370319	F2
374	Recurrent abortion	C0000809	1	79	3.1758858438757365e-05	0.000518723994452	F2
375	Cerebral edema	C0006114	1	80	3.2572319541790407e-05	0.000520110957004	F2
376	Rash and Dermatitis Adverse Event Associated with Chemoradiation	C1559154	1	80	3.2572319541790407e-05	0.000521497919556	PROC
377	Virus Diseases	C0042769	2	772	3.274247092777127e-05	0.000522884882108	HSPA5,PROC
378	Polycythemia	C0032461	1	81	3.3395965662874616e-05	0.00052427184466	F2
379	Pregnancy loss	C0156543	1	81	3.3395965662874616e-05	0.000525658807212	F2
380	Coronary artery stenosis	C0242231	1	81	3.3395965662874616e-05	0.000527045769764	F2
381	Acute Undifferentiated Leukemia	C0280141	1	81	3.3395965662874616e-05	0.000528432732316	HSPA5
382	Prediabetes syndrome	C0362046	1	81	3.3395965662874616e-05	0.000529819694868	HSPA5
383	Hormone refractory prostate cancer	C1328504	1	81	3.3395965662874616e-05	0.00053120665742	PROC
384	Abnormal respiratory system morphology	C4022992	2	778	3.3512882981256986e-05	0.000532593619972	F2,PROC
385	Stromal Neoplasm	C0879615	1	82	3.4229911066496754e-05	0.000533980582524	PROC
386	Gallbladder disease 4	C0012634	2	785	3.442676848453008e-05	0.000535367545076	F2,PROC
387	Carcinoma, Lewis Lung	C0243038	1	83	3.507409770386882e-05	0.000536754507628	F2
388	Hereditary hemochromatosis	C0392514	1	83	3.507409770386882e-05	0.00053814147018	PROC
389	Intestinal polyp	C0021846	1	84	3.592858131795662e-05	0.000539528432732	PROC
390	Mucinous Adenocarcinoma	C0007130	1	86	3.766834787788387e-05	0.000540915395284	PROC
391	Soft Tissue Neoplasms	C0037579	1	86	3.766834787788387e-05	0.000542302357836	PROC
392	Familial Mediterranean fever	C0031069	1	87	3.855357128312864e-05	0.000543689320388	F2
393	Carcinoid tumor no ICD-O subtype	C0334299	1	87	3.855357128312864e-05	0.00054507628294	PROC
394	Acute lymphoid leukemia	C0023449	2	824	3.98242618502298e-05	0.000546463245492	F2,HSPA5
395	Leishmaniasis, Visceral	C0023290	1	89	4.035480427044824e-05	0.000547850208044	HSPA5
396	Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy	C0852949	1	90	4.12708704060627e-05	0.000549237170596	F2
397	High-Grade Prostatic Intraepithelial Neoplasia	C1168327	1	90	4.12708704060627e-05	0.000550624133148	PROC
398	Ulcerative colitis	C0009324	2	837	4.174141319046587e-05	0.0005520110957	F2,PROC
399	Angina, Unstable	C0002965	1	92	4.3133605478251624e-05	0.000553398058252	F2
400	Parathyroid adenoma	C0262587	1	93	4.408035816150235e-05	0.000554785020804	PROC
401	Merkel cell carcinoma	C0007129	1	94	4.5037366776745635e-05	0.000556171983356	PROC
402	Bruising susceptibility	C0009938	1	94	4.5037366776745635e-05	0.000557558945908	F2
403	Arterial thrombosis	C0151942	1	94	4.5037366776745635e-05	0.00055894590846	F2
404	Inflammatory Breast Carcinoma	C0278601	1	94	4.5037366776745635e-05	0.000560332871012	PROC
405	Cerebral palsy, spastic quadriplegic, 3	C0007789	1	95	4.600465813020538e-05	0.000561719833564	F2
406	Kartagener syndrome	C0022521	1	95	4.600465813020538e-05	0.000563106796117	PROC
407	Malaria, Cerebral	C0024534	1	95	4.600465813020538e-05	0.000564493758669	PROC
408	Alcohol abuse	C0085762	1	95	4.600465813020538e-05	0.000565880721221	F2
409	Polyglandular autoimmune syndrome, type 1	C0085409	1	96	4.69822021601507e-05	0.000567267683773	F2
410	Multiple tumors	C0260037	1	96	4.69822021601507e-05	0.000568654646325	PROC
411	Endotoxemia	C0376618	1	96	4.69822021601507e-05	0.000570041608877	F2
412	Testicular malignant germ cell tumor	C0855197	1	96	4.69822021601507e-05	0.000571428571429	PROC
413	Peripheral Arterial Diseases	C1704436	1	96	4.69822021601507e-05	0.000572815533981	F2
414	Interstitial fibrosis	C3887486	1	97	4.7969969516947764e-05	0.000574202496533	HSPA5
415	Hyperplastic Polyp	C0333983	1	98	4.896798628806209e-05	0.000575589459085	PROC
416	Esophageal Squamous Cell Carcinoma	C0279626	2	888	4.985619298425448e-05	0.000576976421637	HSPA5,PROC
417	Hemochromatosis	C0018995	1	99	4.9976194348766434e-05	0.000578363384189	F2
418	Severe Acute Respiratory Syndrome	C1175175	1	99	4.9976194348766434e-05	0.000579750346741	F2
419	Advanced cancer	C0877373	1	100	5.099476528724889e-05	0.000581137309293	HSPA5
420	Myelofibrosis	C0026987	1	102	5.306253064429889e-05	0.000582524271845	PROC
421	Alcoholic Liver Diseases	C0023896	1	103	5.411172142355536e-05	0.000583911234397	HSPA5
422	Adult Acute Lymphocytic Leukemia	C0751606	1	104	5.517121275999681e-05	0.000585298196949	PROC
423	Hereditary factor VIII deficiency disease	C0019069	1	105	5.6240887349789936e-05	0.000586685159501	F2
424	Neoplasm of the rectum	C0034885	1	105	5.6240887349789936e-05	0.000588072122053	PROC
425	NOONAN-LIKE/MULTIPLE GIANT CELL LESION SYNDROME (disorder)	C0221198	1	105	5.6240887349789936e-05	0.000589459084605	F2
426	Rhabdoid Tumor of the Kidney	C0854917	1	105	5.6240887349789936e-05	0.000590846047157	PROC
427	Tumor Immunity	C1519680	1	105	5.6240887349789936e-05	0.000592233009709	PROC
428	precancerous lesions	C0940937	1	106	5.732088788468204e-05	0.000593619972261	PROC
429	Osteosarcoma	C0585442	2	936	5.839606362145755e-05	0.000595006934813	HSPA5,PROC
430	Glomerulosclerosis, Focal Segmental	C0178664	1	109	6.062223169212011e-05	0.000596393897365	HSPA5
431	Intrahepatic Cholangiocarcinoma	C0345905	1	109	6.062223169212011e-05	0.000597780859917	PROC
432	Adenomas, multiple colorectal, 608456 (3)	C0001430	2	975	6.60123835457549e-05	0.000599167822469	HSPA5,PROC
433	early pregnancy	C0747845	1	114	6.632923542893021e-05	0.000600554785021	F2
434	Inflammatory Bowel Diseases	C0021390	2	985	6.806652260415991e-05	0.000601941747573	F2,PROC
435	Nephrolithiasis	C0392525	1	116	6.868363747780659e-05	0.000603328710125	F2
436	Mammary Ductal Carcinoma	C0021367	1	117	6.987619309795079e-05	0.000604715672677	PROC
437	Varicose Veins	C0042345	1	119	7.229197507152563e-05	0.000606102635229	F2
438	Hereditary nonpolyposis colorectal cancer type 8	C1333990	1	119	7.229197507152563e-05	0.000607489597781	PROC
439	Myocardial Infarction	C0027051	2	1019	7.53688762800131e-05	0.000608876560333	F2,HSPA5
440	Carcinoma, Endometrioid	C0206687	1	123	7.724633591321695e-05	0.000610263522885	PROC
441	Cardiovascular Diseases	C0007222	2	1029	7.761184072097027e-05	0.000611650485437	F2,PROC
442	Spinocerebellar ataxia, autosomal recessive 17	C0087012	1	126	8.106950915443001e-05	0.000613037447989	HSPA5
443	Aplasia/Hypoplasia of the skin	C4024737	1	126	8.106950915443001e-05	0.000614424410541	PROC
444	Infertility associated with multi-tailed spermatozoa and excessive DNA	C0021359	1	128	8.366934814962868e-05	0.000615811373093	F2
445	Abnormality of the gingiva	C4021816	1	130	8.631008520143535e-05	0.000617198335645	F2
446	Ventricular Fibrillation Adverse Event	C0232197	1	131	8.764580974052194e-05	0.000618585298197	F2
447	Psoriasis vulgaris	C0263361	1	131	8.764580974052194e-05	0.000619972260749	HSPA5
448	Musculoskeletal Diseases	C0026857	1	132	8.899174001564258e-05	0.000621359223301	F2
449	Lewy Body Disease	C0752347	1	132	8.899174001564258e-05	0.000622746185853	HSPA5
450	Gastrointestinal hemorrhage	C0017181	1	133	9.034787616035711e-05	0.000624133148405	F2
451	Pregnancy Complications, Hematologic	C0032964	1	133	9.034787616035711e-05	0.000625520110957	F2
452	Metastatic malignant neoplasm to brain	C0220650	1	133	9.034787616035711e-05	0.000626907073509	PROC
453	beta Thalassemia	C0005283	1	135	9.309084388142708e-05	0.000628294036061	F2
454	Anaplastic Oligodendroglioma	C0334590	1	135	9.309084388142708e-05	0.000629680998613	PROC
455	Ectodermal dysplasia 11b, hypohidrotic/hair/tooth type, autosomal recessive	C0013575	1	136	9.447764571290929e-05	0.000631067961165	PROC
456	Myositis	C0027121	1	136	9.447764571290929e-05	0.000632454923717	HSPA5
457	Diabetes mellitus type 1	C0011854	2	1104	9.586828301888506e-05	0.000633841886269	HSPA5,PROC
458	Verotoxigenic Escherichia coli gastrointestinal tract infection	C0009450	2	1111	9.770516660501105e-05	0.000635228848821	F2,PROC
459	Adrenoleukodystrophy	C0162309	1	139	9.869927220751418e-05	0.000636615811373	HSPA5
460	Acute GVH disease	C0856825	1	140	0.00010012689391458718	0.000638002773925	PROC
461	Abnormality of the respiratory system	C4018871	2	1121	0.00010036972091431728	0.000639389736477	F2,PROC
462	Mammary Tumorigenesis	C1512981	1	141	0.00010156476840705864	0.000640776699029	PROC
463	Chronic liver disease	C0341439	1	144	0.00010593960517701895	0.000642163661581	F2
464	Intestinal Neoplasms	C0021841	1	145	0.00010741830432170474	0.000643550624133	PROC
465	Neoplasm of the central nervous system	C0085136	1	145	0.00010741830432170474	0.000644937586685	PROC
466	orbit (eye disorders)	C0015397	1	146	0.00010890722017997678	0.000646324549237	F2
467	Lung Neoplasms	C0024121	2	1155	0.00010979086950857475	0.000647711511789	HSPA5,PROC
468	Colorectal Neoplasms	C0009404	2	1164	0.00011237968879440619	0.000649098474341	HSPA5,PROC
469	Barrett Esophagus	C0004763	1	150	0.00011496479832484585	0.000650485436893	PROC
470	Essential thrombocythemia	C0040028	1	150	0.00011496479832484585	0.000651872399445	F2
471	Fetal Diseases	C0015929	1	151	0.0001165047513091988	0.000653259361997	F2
472	Sudden cardiac death	C0085298	1	153	0.00011961519872982773	0.000654646324549	F2
473	Invasive Carcinoma	C1334274	1	154	0.00012118566205343573	0.000656033287101	PROC
474	Dermatological manifestations of systemic disorders	C4025812	1	156	0.00012435728822068892	0.000657420249653	PROC
475	Apnea	C0003578	1	157	0.0001259584506824174	0.000658807212205	F2
476	Adrenocortical carcinoma	C0206686	1	160	0.0001308229395701188	0.000660194174757	PROC
477	Stroke	C0038454	2	1229	0.00013229509441958776	0.000661581137309	F2,PROC
478	Progressive Neoplastic Disease	C0677932	1	161	0.00013246478651973703	0.000662968099861	HSPA5
479	Progressive cGVHD	C3539781	1	161	0.00013246478651973703	0.000664355062413	HSPA5
480	Carotid Stenosis	C0007282	1	162	0.00013411688536235644	0.000665742024965	F2
481	Irritable bowel syndrome with diarrhea	C0022104	1	162	0.00013411688536235644	0.000667128987517	F2
482	Albuminuria	C0001925	1	163	0.00013577915150975173	0.000668515950069	F2
483	Abnormality of the menstrual cycle	C4025888	1	163	0.00013577915150975173	0.000669902912621	F2
484	46,XY gonadal dysgenesis, partial, with minifascicular neuropathy	C0041408	1	164	0.00013745167041900874	0.000671289875173	F2
485	Abnormality of skin morphology	C4023528	2	1261	0.000142909246793943	0.000672676837725	F2,PROC
486	Autosomal dominant non-syndromic sensorineural deafness type DFNA	C0443147	2	1262	0.00014324973142676445	0.000674063800277	F2,PROC
487	Atherosclerosis	C0004153	2	1271	0.00014633891535231758	0.000675450762829	F2,PROC
488	Atrial Fibrillation	C0004238	1	176	0.0001583158537331597	0.000676837725381	F2
489	Synovial sarcoma	C0039101	1	178	0.00016193578786927176	0.000678224687933	PROC
490	Primary Myelofibrosis	C0001815	1	179	0.00016376097415582436	0.000679611650485	PROC
491	Amyotrophy involving the shoulder musculature	C0026846	1	179	0.00016376097415582436	0.000680998613037	HSPA5
492	Menstrual irregularities	C0156404	1	180	0.00016559639066660026	0.000682385575589	F2
493	Abnormality of the cerebral vasculature	C4022001	1	180	0.00016559639066660026	0.000683772538141	PROC
494	Non-Malignant Ascites Adverse Event	C1559271	1	181	0.00016744197983376008	0.000685159500693	F2
495	Familial hypercholesterolemia	C0020445	1	182	0.00016929776880814096	0.000686546463245	F2
496	Abnormality of blood and blood-forming tissues	C0241657	2	1335	0.00016959618448619818	0.000687933425798	F2,PROC
497	Carcinoid tumor	C0007095	1	183	0.0001711636696822838	0.00068932038835	PROC
498	Eclampsia	C0013537	1	183	0.0001711636696822838	0.000690707350902	F2
499	Congenital onset	C1836142	1	185	0.00017492605921054505	0.000692094313454	F2
500	Lymphoma, Large B-Cell, Diffuse	C0024299	2	1362	0.00018010387463929245	0.000693481276006	HSPA5,PROC
501	Abnormality of oral mucosa	C4023170	1	188	0.00018064592754973852	0.000694868238558	F2
502	Aortic Aneurysm, Abdominal	C0162871	1	190	0.0001845100404993527	0.00069625520111	PROC
503	Abnormality of the skin	C0037268	2	1376	0.00018571919401888515	0.000697642163662	F2,PROC
504	Well Differentiated Oligodendroglioma	C0751396	1	191	0.00018645733693434252	0.000699029126214	PROC
505	Polycythemia vera	C0032463	1	192	0.00018841478980391457	0.000700416088766	F2
506	Tuberous sclerosis syndrome	C0041341	1	192	0.00018841478980391457	0.000701803051318	PROC
507	Brain Diseases	C0006111	1	194	0.00019236028083013945	0.00070319001387	F2
508	Connective Tissue Diseases	C0009782	1	196	0.0001963463584370162	0.000704576976422	F2
509	Chronic hepatitis	C0019189	1	197	0.00019835461139816601	0.000705963938974	F2
510	Drug-Induced Liver Injury	C0860207	1	198	0.00020037310029485944	0.000707350901526	F2
511	Death, Sudden, Cardiac	C0011065	1	203	0.00021061772108765808	0.000708737864078	HSPA5
512	Transient ischemic attack	C0007787	1	205	0.00021478670033558966	0.00071012482663	F2
513	Intraocular melanoma	C0220633	1	206	0.000216886458719312	0.000711511789182	PROC
514	Myasthenia Gravis	C0026896	1	209	0.00022324650021710024	0.000712898751734	HSPA5
515	Lupus Erythematosus, Systemic	C0024141	2	1467	0.00022508709739532673	0.000714285714286	F2,HSPA5
516	Hypercholesterolemia, autosomal dominant, type B	C0020443	1	212	0.0002296979830527235	0.000715672676838	F2
517	Cervical intraepithelial neoplasia (Cervical dysplasia)	C0206708	1	212	0.0002296979830527235	0.00071705963939	PROC
518	Endothelial dysfunction	C0856169	1	216	0.00023844195737499074	0.000718446601942	PROC
519	Epstein-Barr Virus Infections	C0149678	1	219	0.0002451065323956225	0.000719833564494	PROC
520	Restenosis	C0333186	1	220	0.00024734831386608036	0.000721220527046	F2
521	Intracranial hemorrhage	C0151699	1	222	0.0002518623198100034	0.000722607489598	F2
522	Steatohepatitis	C2711227	1	222	0.0002518623198100034	0.00072399445215	HSPA5
523	Liver failure acute infantile	C0085605	1	223	0.00025413457158418584	0.000725381414702	F2
524	Anaplastic thyroid carcinoma	C0238461	1	223	0.00025413457158418584	0.000726768377254	PROC
525	Ductal Carcinoma	C1527349	1	223	0.00025413457158418584	0.000728155339806	PROC
526	Seizures, Febrile	C0036572	2	1535	0.0002578842006203397	0.000729542302358	F2,PROC
527	Secondary malignant neoplasm of pancreas	C3266877	2	1540	0.00026041412796640184	0.00073092926491	HSPA5,PROC
528	Anaplasia	C0002793	1	231	0.000272677307084801	0.000732316227462	PROC
529	Invasive Ductal Breast Carcinoma	C1134719	1	231	0.000272677307084801	0.000733703190014	HSPA5
530	Abnormality of cardiovascular system electrophysiology	C0243050	2	1568	0.00027488794845487163	0.000735090152566	F2,PROC
531	Lymphoproliferative disorder	C0024314	1	236	0.00028459587887430526	0.000736477115118	F2
532	Dermal atrophy	C0151514	1	237	0.0002870099897162026	0.00073786407767	HSPA5
533	Acute myocardial infarction	C0155626	1	237	0.0002870099897162026	0.000739251040222	F2
534	Malignant neoplasm of pancreas	C0346647	2	1625	0.0003059896601345091	0.000740638002774	HSPA5,PROC
535	Myeloproliferative Disorders	C0027022	1	245	0.00030668728506910714	0.000742024965326	F2
536	Hypertension	C0020538	2	1647	0.000318594433275754	0.000743411927878	F2,PROC
537	Malignant tumor of testis	C0153594	1	251	0.0003218703840143222	0.00074479889043	PROC
538	Malignant gastrointestinal tract tumors	C0685938	1	251	0.0003218703840143222	0.000746185852982	PROC
539	Germ cell neoplasia	C0205851	1	252	0.00032443629523115636	0.000747572815534	PROC
540	Neuroendocrine neoplasm	C0206754	1	252	0.00032443629523115636	0.000748959778086	PROC
541	Thrombocytopenia, platelet dysfunction, hemolysis, and imbalanced globin synthesis	C0040034	1	253	0.0003270123426656335	0.000750346740638	F2
542	Abnormality of the integument	C4025761	2	1665	0.0003291612146757439	0.00075173370319	F2,PROC
543	Fibrosarcoma	C0016057	1	254	0.00032959849504632377	0.000753120665742	HSPA5
544	Adenoma of large intestine	C1302401	1	257	0.0003374176105118698	0.000754507628294	PROC
545	Microphthalmia syndromic 6	C0026010	1	258	0.0003400442341381371	0.000755894590846	PROC
546	Pancreatic Carcinoma	C0235974	2	1690	0.00034422120677257695	0.000757281553398	HSPA5,PROC
547	Spontaneous abortion	C0000786	1	260	0.0003453277808911359	0.00075866851595	F2
548	Alzheimer Disease	C0002395	2	1699	0.0003497532628966571	0.000760055478502	F2,HSPA5
549	 Adenocarcinoma, ovarian, somatic, 167000 (3)	C0001418	2	1700	0.00035037155619854765	0.000761442441054	HSPA5,PROC
550	Encephalopathy, acute, infection-induced, 4, susceptibility to	C0085584	1	262	0.000350651687427872	0.000762829403606	F2
551	Cutaneous malignant melanoma 3	C0151779	1	264	0.0003560161470173018	0.000764216366158	PROC
552	Experimental Organism Basal Cell Carcinoma	C3811653	1	264	0.0003560161470173018	0.00076560332871	PROC
553	Hypoglycemia, neonatal, simulating foetopathia diabetica	C0020615	1	265	0.00035871350074123676	0.000766990291262	F2
554	Malignant mesothelioma	C0345967	1	266	0.0003614209156168613	0.000768377253814	PROC
555	Gastrointestinal Neoplasms	C0017185	1	268	0.0003668661311514443	0.000769764216366	PROC
556	Subarachnoid hemorrhage	C0038525	1	268	0.0003668661311514443	0.000771151178918	F2
557	Colon cancer	C0007102	2	1727	0.0003673424380324919	0.00077253814147	HSPA5,PROC
558	Ankylosing spondylitis	C0038013	1	269	0.0003696038972735849	0.000773925104022	HSPA5
559	Anemia, Sickle Cell	C0002895	1	271	0.0003751097163506856	0.000775312066574	F2
560	Hepatitis B, Chronic	C0524909	1	272	0.00037787776577924426	0.000776699029126	F2
561	Cerebral ischemia	C0917798	1	272	0.00037787776577924426	0.000778085991678	F2
562	Pancreatitis	C0030305	1	277	0.00039186950053282654	0.00077947295423	PROC
563	Choriocarcinoma	C0008497	1	279	0.00039753684768761843	0.000780859916782	HSPA5
564	polyps	C0032584	1	284	0.0004118818073237662	0.000782246879334	PROC
565	Splenomegaly	C0038002	1	285	0.0004147810787404893	0.000783633841886	F2
566	Pituitary adenoma	C0032000	1	286	0.0004176904706159057	0.000785020804438	PROC
567	Rectal Carcinoma	C0149978	1	286	0.0004176904706159057	0.00078640776699	PROC
568	Gastric Adenocarcinoma	C0278701	1	286	0.0004176904706159057	0.000787794729542	HSPA5
569	Hyperlipidemia, combined, 1	C0020473	1	293	0.00043833822316330373	0.000789181692094	F2
570	Ischaemic cerebral infarction	C0007785	1	297	0.000450358722523414	0.000790568654646	F2
571	Helicobacter pylori infection	C0850666	1	297	0.000450358722523414	0.000791955617198	PROC
572	Squamous cell carcinoma	C0007137	2	1855	0.00045527933977540513	0.00079334257975	HSPA5,PROC
573	Rheumatoid arthritis	C0003873	2	1856	0.00045601644859161183	0.000794729542302	F2,PROC
574	Carcinoma of colon	C0699790	2	1856	0.00045601644859161183	0.000796116504854	HSPA5,PROC
575	Adenocarcinoma Of Esophagus	C0279628	1	300	0.0004594798883283957	0.000797503467406	PROC
576	Agenesis of corpus callosum	C0175754	1	301	0.00046254047253635466	0.000798890429958	PROC
577	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11	C0026850	1	311	0.0004936997650090147	0.00080027739251	PROC
578	Leukemia, Lymphocytic, Chronic, B-Cell	C0023418	2	1913	0.0004993584525028183	0.000801664355062	HSPA5,PROC
579	Graft-versus-host disease, susceptibility to	C0018133	1	317	0.0005128783839701834	0.000803051317614	PROC
580	Pancreatic adenocarcinoma	C0281361	1	320	0.0005226036317352856	0.000804438280166	PROC
581	Tumor Progression	C0178874	2	1969	0.000544532804693354	0.000805825242718	HSPA5,PROC
582	Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse	C0334634	1	327	0.0005456476043731451	0.00080721220527	HSPA5
583	Diabetes mellitus type 2	C0011860	2	1972	0.0005470268601119876	0.000808599167822	F2,HSPA5
584	Non-small cell lung carcinoma	C0007131	2	1993	0.0005646986683327526	0.000809986130374	HSPA5,PROC
585	Migraine Disorders	C0149931	1	333	0.0005657915351460208	0.000811373092926	F2
586	Metastatic melanoma	C0278883	1	333	0.0005657915351460208	0.000812760055479	HSPA5
587	Glioma	C0017638	2	1997	0.0005681073325243258	0.000814147018031	F2,HSPA5
588	Autosomal recessive inheritance	C0441748	2	2006	0.0005758268512243703	0.000815533980583	F2,PROC
589	Ischemic Cerebrovascular Accident	C3272363	1	338	0.0005828544671844238	0.000816920943135	F2
590	Gastrointestinal stromal tumor	C0238198	1	340	0.0005897498761117115	0.000818307905687	PROC
591	Abnormality of skin pigmentation	C1260926	1	344	0.0006036612677275954	0.000819694868239	PROC
592	Wilms Tumor	C0027708	1	352	0.00063196568056334	0.000821081830791	PROC
593	Pulmonary Disease, Chronic Obstructive	C0024115	1	377	0.0007245519074371432	0.000822468793343	F2
594	Hereditary pancreatitis	C0238339	1	377	0.0007245519074371432	0.000823855755895	HSPA5
595	Intrauterine growth retardation	C0015934	1	379	0.0007322291686339133	0.000825242718447	F2
596	Obesity	C0028754	2	2181	0.0007401474835646571	0.000826629680999	F2,HSPA5
597	Anxiety Disorders	C0003469	1	383	0.0007477038286269888	0.000828016643551	PROC
598	Heart Diseases	C0018799	1	386	0.000759414802026126	0.000829403606103	F2
599	Experimental Autoimmune Encephalomyelitis	C0014072	1	389	0.0007712158097840094	0.000830790568655	PROC
600	Urothelial Carcinoma	C0007138	1	391	0.000779133097402962	0.000832177531207	HSPA5
601	Pulmonary fibrosis and/or bone marrow failure, telomere-related, 4	C0034069	1	392	0.0007831067890693433	0.000833564493759	F2
602	Lung cancer	C0684249	2	2234	0.0007954538101303532	0.000834951456311	HSPA5,PROC
603	Abnormality of female internal genitalia	C4025900	1	398	0.000807158586747847	0.000836338418863	F2
604	Ischemic stroke	C0948008	1	401	0.0008193193059216064	0.000837725381415	F2
